Abstract
Background/Aim Nerve conduction speed (NCS) abnormalities are considered to be early signs of diabetic peripheral neuropathy. We investigated which determinants impact the NCS and how it is related to markers of metabolic control in children and young adults with diabetes mellitus.
Method Fifty-four children aged five to 23 years suffering from type I diabetes mellitus were recruited into this study, which was conducted at the Children’s Hospital of Eastern Switzerland in St Gallen from March 2016 to June 2022. The metabolic control parameters were recorded and a nerve conduction study analyzing three motor nerves and one sensory nerve was performed. The data were compared to a control population of healthy children of the same height, and the height-adjusted NCS (dNCS) was analysed.
Results For all four nerves under investigation, a statistically significant drop in the NCS of approximately 5 m/s independent of metabolic control was found, the peroneal nerve being the most sensitive. The NCS of the peroneal nerve correlated significantly negatively with the long-term haemoglobin with bound glucose (HbA1c) and highly significantly negatively with the standard deviation of mean glucose (SD), but there was only a trend with the HbA1c and the time in range (TIR) at the time of neurography.
Interpretation All patients with diabetes mellitus showed a reduced NCS, partly independent of metabolic control. This may be due to a lack of the C-peptide, which regulates critical axonal membrane enzymes. High glucose variability clearly increases the risk of neuropathy, together with but also independently of the mean plasma glucose level.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the ethics committee of Eastern Switzerland (Ethikkommission Ostschweiz, approval no: 22/018) and registered at the Swiss project database (2022-00216). Written informed consent was obtained from the caregivers before the inclusion of participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Sarah.Oberhauser{at}kispisg.ch; dagmar.lallemand{at}kispisg.ch; juerg.luetschg{at}unibas.ch philip.broser{at}me.com;
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- AITD
- autoimmune thyroid disease
- CGM
- continuous glucose monitoring
- CMAP
- compound muscle action potential
- CD
- coeliac disease
- CV
- coefficient of variation
- CSII
- continuous subcutaneous insulin infusion
- DM
- diabetes mellitus
- DPN
- diabetic peripheral neuropathy
- dNCS
- residual drop in the peroneal NCS after correction for body height
- GAD
- glutamic acid decarboxylase antibody
- glucose SD
- standard deviation of mean glucose
- HbA1c
- haemoglobin with bound glucose
- IA
- insulin antibody
- IA2
- tyrosine phosphatase 2 antibody
- ICA
- pancreatic cell antibody
- MODY
- maturity onset diabetes of the young
- NCS
- nerve conduction speed
- R
- degree of regression
- SD
- standard deviation
- T1DM
- type 1 diabetes mellitus
- TIR
- time in range
- y
- years
- ZnT8
- zinc transporter 8 antibody